HOBSCOTCH for Young Adults with Epilepsy
Official title: HOBSCOTCH-YOUTH and Young Adults
Run by Dartmouth-Hitchcock Medical Center · NCT07735715 · Data updated 2026-11-12
This study tests a nine-week home-based program to help young adults (18-29) with epilepsy improve thinking, memory, and quality of life, and also tests a version adapted for youths (13-17) with a parent to see if it helps their thinking, memory, and stress levels for families.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 29 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 1 site (Lebanon, New Hampshire) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | May 1, 2029 |
| Study ends | July 31, 2029 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07735715 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Young adults aged 18-29 with epilepsy, and youths aged 13-17 with epilepsy (with a participating parent/guardian for the youth), who have subjective cognitive concerns and access to internet and a device.
✕Probably not a fit
Participants without cognitive concerns or those unable to engage in home-based, internet-enabled sessions may see little or no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial will enroll about 260 young adults with epilepsy and 40 youths with epilepsy along with a parent or guardian. Participants will complete questionnaires before and after the program to measure changes in cognitive function and quality of life. The intervention consists of nine weekly one-hour, home-based sessions led by a coach via computer or phone. A modified version of the program for youth is being evaluated for cognitive benefits and family stress. The study is conducted at a single site under Dartmouth-Hitchcock Medical Center.
Why it matters
Potential benefit: If successful, participants may experience improved memory, attention, and overall quality of life related to epilepsy.
How similar studies have gone: Prior home-based self-management programs for epilepsy have shown signals of cognitive and quality-of-life improvements, but this specific youth-adapted approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion Criteria for Young Adults with Epilepsy (YAWE) and Youth with Epilepsy (YWE): * Age 18 - 29 years for YAWE * Age 13 - 17 years for YWE * For YWE at least one parent or legal guardian provides consent and agrees to participate * Diagnosis of epilepsy (controlled or uncontrolled seizures) * Subjective cognitive complaints (memory, attention, learning, problem solving, executive function, planning) * Literate and proficient in English * Telephone access * Internet Access. Inclusion Criteria for Parent of Youth with Epilepsy (YWE): * Parent or legal guardian of a youth with epilepsy (age 13 - 17 years) * Literate and proficient in English * Telephone access * Internet Access Exclusion Criteria: * Active psychosis (any participant) * Illicit substance abuse (any participant) * Severe cognitive/intellectual disability (any participant) * YWE cannot participate without a parent and parent's consent (or legal guardian) * YWE cannot participate without assent even if a parent or legal guardian gives consent
Where it's running
-
Dartmouth-Hitchcock
Lebanon, New Hampshire, United States Recruiting
Study contacts
- Principal investigator: Elaine T. Kiriakopoulos, MD, MPH, MSc — Dartmouth-Hitchcock/Geisel School of Medicine-Dartmouth
- Study coordinator: Wren M Kaden, BA
- Email: wren.m.kaden@hitchcock.org
- Phone: 603-650-4225
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.